Insider: Byam Rebecca Chief Financial Officer - HCW Biologics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 43,010 | 0 | 43,010 |
| Value | $175,050.70 | $0.00 | $175,050.70 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/08/2025 | AAP | 8,462 | Direct | COM | $26.00 | $220,012.00 | 43,010 |
| 09/13/2023 | AAP | 5,000 | Direct | COM | $2.10 | $10,490.00 | 573,946 |
| 09/12/2023 | AAP | 5,000 | Direct | COM | $2.09 | $10,442.00 | 568,946 |
| 09/11/2023 | AAP | 5,000 | Direct | COM | $2.05 | $10,273.00 | 563,946 |
| 09/08/2023 | AAP | 5,000 | Direct | COM | $2.02 | $10,111.00 | 558,946 |
| 09/07/2023 | AAP | 5,000 | Direct | COM | $1.95 | $9,742.00 | 553,946 |
| 09/06/2023 | AAP | 5,000 | Direct | COM | $1.95 | $9,749.00 | 548,946 |
| 06/09/2023 | AAP | 20,000 | Direct | COM | $2.06 | $41,286.00 | 543,946 |
| 06/08/2023 | AAP | 4,696 | Direct | COM | $2.21 | $10,387.55 | 523,946 |
| 06/07/2023 | AAP | 20,000 | Direct | COM | $2.03 | $40,632.00 | 519,250 |
| 06/06/2023 | AAP | 19,062 | Direct | COM | $1.82 | $34,778.62 | 499,250 |
| 06/05/2023 | AAP | 20,000 | Direct | COM | $1.67 | $33,344.00 | 480,188 |
| 05/26/2023 | AAP | 20,000 | Direct | COM | $1.66 | $33,196.00 | 460,188 |
| 05/25/2023 | AAP | 20,000 | Direct | COM | $1.62 | $32,348.00 | 440,188 |
| 05/24/2023 | AAP | 20,000 | Direct | COM | $1.61 | $32,150.00 | 420,188 |
| 05/23/2023 | AAP | 5,036 | Direct | COM | $1.57 | $7,887.38 | 400,188 |
| 05/22/2023 | AAP | 33,450 | Direct | COM | $1.53 | $51,044.70 | 395,152 |
| 09/14/2022 | AAP | 15,000 | Direct | COM | $2.58 | $38,650.50 | 327,952 |
| 09/13/2022 | AAP | 15,000 | Direct | COM | $2.58 | $38,650.50 | 312,952 |
| 09/12/2022 | AAP | 15,000 | Direct | COM | $2.65 | $39,763.50 | 297,952 |
| 08/31/2022 | AAP | 10,000 | Direct | COM | $2.56 | $25,572.00 | 282,952 |
| 08/30/2022 | AAP | 7,200 | Direct | COM | $2.55 | $18,341.28 | 272,952 |
| 08/29/2022 | AAP | 10,000 | Direct | COM | $2.57 | $25,662.00 | 265,752 |
| 08/26/2022 | AAP | 10,000 | Direct | COM | $2.54 | $25,358.00 | 255,752 |
| 08/25/2022 | AAP | 40,300 | Direct | COM | $2.59 | $104,522.08 | 245,752 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research